WEBSITECHANGES

Website Changes

---

02/17/2019

why some brain tumors respond to immunotherapy

---

02/17/2019

Confirmation of high therapeutic effect in doctor-led clinical trials of viral therapy for brain tumor - Application for approval for the manufacture and marketing of the first cancer treatment viral drug in Japan -

---

02/15/2019

Statins, NSAIDS Have No Apparent Survival Benefit for Grade IV Glioma

---

02/14/2019

Contractor Advisory Committee (CAC) Meeting Information - Tumor Treatment Field Therapy (L34823)

---

02/14/2019

University of Minnesota First in U.S. to Offer New Targeted Therapy for Recurrent Brain Tumors

---

02/13/2019

Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation

---

02/13/2019

Progesterone is more effective than dexamethasone in prolonging overall survival and preserving neurologic functions in experimental animals with orthotopic glioblastoma allografts.

---

02/13/2019

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema.

---

02/13/2019

Race influences survival in glioblastoma patients with KPS =?80 and associates with genetic markers of retinoic acid metabolism.

---

02/13/2019

Oncotelic Reports that It`s Proprietary In-Situ Cancer Vaccine Improved Survival over Standard Chemotherapy in Patients with Recurrent Metastatic Pancreas Cancer and Recurrent High Grade Glioma

---

02/12/2019

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review

---

02/12/2019

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.

---

02/11/2019

Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial

---

02/10/2019

Medicenna Presents Promising Clinical Data from Phase 2b Recurrent Glioblastoma Trial of MDNA55

---

02/06/2019

Brain Tumor `Pied Piper` Device Gains Breakthrough Status

---

02/05/2019

Moleculin Biotech (MBRX) Announces FDA Orphan Drug Designation for its Brain Tumor Drug

---

01/31/2019

GT Medical Technologies Announces Publication of Data Showing Company’s Targeted Therapy is Effective for Treating Recurrences of Common Type of Brain Tumor

---

01/30/2019

Musella Foundation awards a pediatric brain tumor research grant!

---

01/26/2019

Early clinical trials of Toca 511 and Toca FC show a promising novel treatment for recurrent malignant glioma.

---

01/26/2019

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma.

---

01/26/2019

Alternating Electric Fields (TTFields) Activate Cav1.2 Channels in Human Glioblastoma Cells.

---

01/26/2019

Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial

---

01/26/2019

Effect of health disparities on overall survival of patients with glioblastoma.

---

01/25/2019

New Liquid Biopsy Test Detects Brain Cancer, But It Doesn`t Use Blood

---

01/23/2019

Regorafenib Doubles 12-Month Survival Compared with Lomustine in Recurrent GBM

---